Sanofi: raises FY EPS target.
(CercleFinance.com) - Sanofi has increased its EPS outlook for 2017 to broadly stable at constant exchange rates, excluding any major unforeseen adverse events.
In Q2, the pharmaceutical group's EPS from its businesses rose by 1.5% to 1.35 euros, while the operating result from its businesses was up 4.1% to 2,299 million euros, again at constant exchange rates.
Turnover amounted to 8,663 million, up 6.4% as reported, and up 5.5% at constant exchange rates, reflecting changes in the scope of its global public health and vaccines entities. Organic growth reached 0.6%.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
In Q2, the pharmaceutical group's EPS from its businesses rose by 1.5% to 1.35 euros, while the operating result from its businesses was up 4.1% to 2,299 million euros, again at constant exchange rates.
Turnover amounted to 8,663 million, up 6.4% as reported, and up 5.5% at constant exchange rates, reflecting changes in the scope of its global public health and vaccines entities. Organic growth reached 0.6%.
Copyright (c) 2017 CercleFinance.com. All rights reserved.